This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1998-2006.
Location History:
- Groton, CT (US) (1998)
- Norwich, CT (US) (2006)
Company Filing History:
Years Active: 1998-2006
Title: The Innovative Contributions of Steven D Heck
Introduction
Steven D Heck is a notable inventor based in Norwich, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
One of his latest patents involves 3-azabicyclo[3.1.0]hexane derivatives. This invention provides a compound of the formula I, wherein X, Q, n, R, R, R, R, R, R, R, R, R, and R are defined. Compounds of formula I have demonstrated activity as opioid receptor antagonists. Additionally, the invention includes pharmaceutical compositions and therapeutic methods that utilize these compounds. Another patent focuses on calcium channel blocking polypeptides derived from Filistata hibernalis, showcasing his diverse research interests.
Career Highlights
Steven D Heck is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to innovative drug development and research initiatives. His expertise in pharmacology and chemistry has been instrumental in advancing therapeutic solutions.
Collaborations
Throughout his career, Steven has collaborated with esteemed colleagues, including Deane M Nason, II and Nicholas A Saccomano. These collaborations have fostered a productive environment for innovation and research.
Conclusion
In summary, Steven D Heck's contributions to the field of pharmaceuticals through his patents and work at Pfizer Corporation highlight his role as an influential inventor. His research continues to impact the development of new therapeutic compounds.